|
JPS6333341A
(ja)
|
1986-07-28 |
1988-02-13 |
Seitetsu Kagaku Co Ltd |
配糖体の処理方法
|
|
US4843071A
(en)
|
1986-12-05 |
1989-06-27 |
Serotonin Industries Of Charleston |
Method and composition for treating obesity, drug abuse, and narcolepsy
|
|
JP2851054B2
(ja)
|
1989-03-15 |
1999-01-27 |
サントリー株式会社 |
ベンズオキセピン誘導体
|
|
US5169780A
(en)
|
1989-06-22 |
1992-12-08 |
Celgene Corporation |
Enantiomeric enrichment and stereoselective synthesis of chiral amines
|
|
FR2656310B1
(fr)
|
1989-12-22 |
1992-05-07 |
Roussel Uclaf |
Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
|
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
CA2157594A1
(en)
|
1993-03-10 |
1994-09-15 |
Leah L. Frye |
Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants
|
|
IT1265001B1
(it)
|
1993-12-16 |
1996-10-17 |
Zambon Spa |
Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
|
|
NZ278765A
(en)
|
1993-12-30 |
1998-05-27 |
Harvard College |
Vertebrate proteins involved in spatial arrangements of differentiated tissues called hedgehog proteins, their production and use
|
|
US6281332B1
(en)
|
1994-12-02 |
2001-08-28 |
The Johns Hopkins University School Of Medicine |
Hedgehog-derived polypeptides
|
|
AU7364896A
(en)
|
1995-10-10 |
1997-04-30 |
Marilyn Strube |
Treatment of pruritus with vitamin d and analogs thereof
|
|
US6184381B1
(en)
|
1995-12-06 |
2001-02-06 |
Japan Science & Technology Corp. |
Process for preparing optically active compounds
|
|
US6887820B1
(en)
|
1995-12-06 |
2005-05-03 |
Japan Science And Technology Corporation |
Method for producing optically active compounds
|
|
GB9706321D0
(en)
|
1997-03-26 |
1997-05-14 |
Zeneca Ltd |
Catalytic hydrogenation
|
|
US7741298B2
(en)
|
1997-06-20 |
2010-06-22 |
New York University |
Method and compositions for inhibiting tumorigenesis
|
|
US6238876B1
(en)
|
1997-06-20 |
2001-05-29 |
New York University |
Methods and materials for the diagnosis and treatment of sporadic basal cell carcinoma
|
|
US7709454B2
(en)
|
1997-06-20 |
2010-05-04 |
New York University |
Methods and compositions for inhibiting tumorigenesis
|
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
|
US6231875B1
(en)
|
1998-03-31 |
2001-05-15 |
Johnson & Johnson Consumer Companies, Inc. |
Acidified composition for topical treatment of nail and skin conditions
|
|
US7291626B1
(en)
|
1998-04-09 |
2007-11-06 |
John Hopkins University School Of Medicine |
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6867216B1
(en)
|
1998-04-09 |
2005-03-15 |
Johns Hopkins University School Of Medicine |
Inhibitors of hedgehog signal pathways, compositions and uses related thereto
|
|
US6432970B2
(en)
|
1998-04-09 |
2002-08-13 |
Johns Hopkins University School Of Medicine |
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
|
|
WO2000009144A1
(en)
*
|
1998-08-13 |
2000-02-24 |
University Of Southern California |
Methods to increase blood flow to ischemic tissue
|
|
GB9821067D0
(en)
|
1998-09-29 |
1998-11-18 |
Zeneca Ltd |
Transfer hydrogenation process
|
|
US6291516B1
(en)
|
1999-01-13 |
2001-09-18 |
Curis, Inc. |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
|
FR2796938B1
(fr)
|
1999-07-29 |
2004-04-02 |
Ppg Sipsy |
Nouveaux derives chiraux n-substitues de la norephedrine, leur preparation et leur utilisation pour la synthese de composes fonctionnalises optiquement actifs par transfert d'hydrogene
|
|
US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
CA2385736C
(en)
|
1999-09-16 |
2011-11-15 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6993456B2
(en)
|
1999-09-30 |
2006-01-31 |
Rockwell Automation Technologies, Inc. |
Mechanical-electrical template based method and apparatus
|
|
EP1235851B1
(en)
|
1999-10-13 |
2006-05-31 |
Johns Hopkins University School of Medicine |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
|
EP1227805B2
(en)
|
1999-10-14 |
2011-02-23 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6552016B1
(en)
|
1999-10-14 |
2003-04-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6893637B1
(en)
|
1999-10-21 |
2005-05-17 |
Zymogenetics, Inc. |
Method of treating fibrosis
|
|
IL133809A0
(en)
|
1999-12-30 |
2001-04-30 |
Yeda Res & Dev |
Steroidal alkaloids and pharmaceutical compositions comprising them
|
|
KR20010077591A
(ko)
|
2000-02-03 |
2001-08-20 |
복성해 |
아라니콜라 프로테오리티쿠스에서 분리한 신규 금속성단백질 분해효소 및 그의 유전자
|
|
DE60113823T3
(de)
|
2000-03-30 |
2010-07-01 |
Curis, Inc., Cambridge |
Kleine organische moleküle als regulatoren der zellproliferation
|
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
WO2001090077A1
(en)
|
2000-05-19 |
2001-11-29 |
Guilford Pharmaceuticals, Inc. |
Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
|
|
CA2425356C
(en)
|
2000-10-13 |
2015-10-06 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
|
US7708998B2
(en)
|
2000-10-13 |
2010-05-04 |
Curis, Inc. |
Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
|
|
GB0029356D0
(en)
|
2000-12-01 |
2001-01-17 |
Avecia Ltd |
Transfer hydrogenation
|
|
US6456928B1
(en)
|
2000-12-29 |
2002-09-24 |
Honeywell International Inc. |
Prognostics monitor for systems that are subject to failure
|
|
JP5354763B2
(ja)
|
2001-03-16 |
2013-11-27 |
アルザ・コーポレーシヨン |
フェンタニルを投与するための経皮的張り付け剤
|
|
AU2002247847A1
(en)
|
2001-04-09 |
2002-10-21 |
Lorantis Limited |
Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
|
|
AUPR602401A0
(en)
|
2001-06-29 |
2001-07-26 |
Smart Drug Systems Inc |
Sustained release delivery system
|
|
CA2452152A1
(en)
*
|
2001-07-02 |
2002-10-10 |
Sinan Tas |
Use of cyclopamine in the treatment of psoriasis
|
|
CA2452151C
(en)
|
2001-07-02 |
2012-01-03 |
Sinan Tas |
Use of cyclopamine, an inducer of the differentiation and apoptosis of the basal cell carcinoma (bcc) cells, in the treatment of bcc's and other tumors that use the hedgehog/smoothened pathway for proliferation of apoptosis
|
|
RU2308948C2
(ru)
*
|
2001-07-02 |
2007-10-27 |
ТАШ Шинан |
Применение циклопамина для лечения базально-клеточной эпителиомы (карциномы) и других опухолей
|
|
NZ530580A
(en)
|
2001-07-27 |
2007-02-23 |
Curis Inc |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
JP2003192919A
(ja)
*
|
2001-10-17 |
2003-07-09 |
Asahi Denka Kogyo Kk |
難燃性合成樹脂組成物
|
|
CA2468434A1
(en)
|
2001-11-09 |
2003-05-15 |
National Research Council Of Canada |
Volatile noble metal organometallic complexes
|
|
US7105637B2
(en)
|
2002-02-15 |
2006-09-12 |
William Marsh Rice University |
Dehydro-estriol (8-DHE3) and dehydro-pregnanetriol (7-DHPT), methods of their synthesis
|
|
US20030175355A1
(en)
*
|
2002-03-07 |
2003-09-18 |
Tobyn Michael John |
Fast melt multiparticulate formulations for oral delivery
|
|
CA2483311A1
(en)
|
2002-04-22 |
2003-10-30 |
Philip A. Beachy |
Modulators of hedgehog signaling pathways, compositions and uses related thereto
|
|
GB0210234D0
(en)
|
2002-05-03 |
2002-06-12 |
Novartis Ag |
Process for the manufacture of organic compounds
|
|
EP1541579A1
(en)
|
2002-06-20 |
2005-06-15 |
Nippon Suisan Kaisha, Ltd. |
Produrg, medicinal utilization thereof and process for producing the same
|
|
AU2003265853A1
(en)
|
2002-08-29 |
2004-03-19 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
|
GB0221539D0
(en)
|
2002-09-17 |
2002-10-23 |
Medical Res Council |
Methods of treatment
|
|
GB0230217D0
(en)
|
2002-12-27 |
2003-02-05 |
Biotica Tech Ltd |
Borrelidin-producing polyketide synthase and its uses
|
|
FR2850022B1
(fr)
|
2003-01-22 |
2006-09-08 |
Centre Nat Rech Scient |
Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
|
|
EP1639097B1
(en)
|
2003-06-25 |
2013-08-07 |
Ottawa Health Research Institute |
Methods and compositions for modulating stem cell growth and differentiation
|
|
WO2005013800A2
(en)
|
2003-07-15 |
2005-02-17 |
The Johns Hopkins University |
Elevated hedgehog pathway activity in digestive system tumors, and methods of treating digestive system tumors having elevated hedgehog pathway activity
|
|
WO2005033288A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
EP1673437A4
(en)
|
2003-10-01 |
2007-07-11 |
Invitrogen Corp |
COMPOSITIONS AND METHODS FOR SYNTHESIS, PURIFICATION AND DETECTION OF BIOMOLECULES
|
|
US20070231828A1
(en)
|
2003-10-01 |
2007-10-04 |
Johns Hopkins University |
Methods of predicting behavior of cancers
|
|
WO2005032343A2
(en)
|
2003-10-01 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog signaling in prostate regeneration neoplasia and metastasis
|
|
WO2005042700A2
(en)
|
2003-10-20 |
2005-05-12 |
The Johns Hopkins University |
Use of hedgehog pathway inhibitors in small-cell lung cancer
|
|
US20070219250A1
(en)
|
2003-11-28 |
2007-09-20 |
Romi Singh |
Pharmaceutical Compositions of Nateglinide
|
|
CN101018783B
(zh)
|
2004-04-30 |
2012-11-21 |
遗传技术研究公司 |
Hedgehog信号传导途径的喹喔啉抑制剂
|
|
CA2579078C
(en)
*
|
2004-08-27 |
2016-11-22 |
Infinity Pharmaceuticals, Inc. |
Cyclopamine analogues and methods of use thereof
|
|
KR20180122750A
(ko)
|
2004-09-02 |
2018-11-13 |
제넨테크, 인크. |
헤지호그 신호전달에 대한 피리딜 억제제
|
|
JP2008514726A
(ja)
|
2004-09-30 |
2008-05-08 |
ザ ユニヴァーシティー オヴ シカゴ |
ヘッジホッグ阻害剤、放射線及び化学療法薬の併用療法
|
|
KR20070083836A
(ko)
|
2004-10-28 |
2007-08-24 |
아이알엠 엘엘씨 |
헷지혹 경로 조절제로서의 화합물 및 조성물
|
|
US20090208579A1
(en)
*
|
2004-12-27 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
|
|
US20060252073A1
(en)
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
US8668905B2
(en)
|
2005-05-12 |
2014-03-11 |
University Of South Florida |
P53 vaccines for the treatment of cancers
|
|
EP2404602A1
(en)
|
2005-08-22 |
2012-01-11 |
The Johns Hopkins University |
Hedgehog pathway antagonists to treat cancer
|
|
JP4712524B2
(ja)
|
2005-10-28 |
2011-06-29 |
富士通コンポーネント株式会社 |
入力デバイス及び電子機器
|
|
CA2625210A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
AU2006311808A1
(en)
|
2005-11-04 |
2007-05-18 |
Merck Sharp & Dohme Corp. |
Methods of using SAHA and bortezomib for treating cancer
|
|
WO2007054623A2
(en)
|
2005-11-11 |
2007-05-18 |
Licentia Oy |
Mammalian hedgehog signaling inhiabitors
|
|
US8101610B2
(en)
|
2005-11-14 |
2012-01-24 |
Genentech, Inc. |
Bisamide inhibitors of hedgehog signaling
|
|
US20090263317A1
(en)
|
2005-12-15 |
2009-10-22 |
Wei Chen |
Method of screening the activity of the smoothened receptor to identify theraputic modulation agents or diagnose disease
|
|
CA2635718A1
(en)
|
2005-12-27 |
2007-08-09 |
Genentech, Inc. |
Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders
|
|
EP1818411A1
(en)
|
2006-02-13 |
2007-08-15 |
Lonza AG |
Process for the preparation of optically active chiral amines
|
|
US20080019961A1
(en)
|
2006-02-21 |
2008-01-24 |
Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
US20110034498A1
(en)
|
2006-03-24 |
2011-02-10 |
Mcgovern Karen J |
Dosing regimens for the treatment of cancer
|
|
MX2008013204A
(es)
|
2006-04-14 |
2008-10-22 |
Novartis Ag |
Uso de biarilcarboxamidas en el tratamiento de trastornos relacionados con la ruta hedgehog.
|
|
UA93548C2
(uk)
|
2006-05-05 |
2011-02-25 |
Айерем Елелсі |
Сполуки та композиції як модулятори хеджхогівського сигнального шляху
|
|
DE102006031358A1
(de)
*
|
2006-07-05 |
2008-01-17 |
Schott Ag |
Verfahren zur Gehäusung optischer oder optoelektronischer Bauteile, sowie verfahrensgemäß herstellbares optisches oder optoelektronisches Gehäuseelement
|
|
WO2008011071A2
(en)
|
2006-07-19 |
2008-01-24 |
The Regents Of The University Of California |
Interactions of hedgehog and liver x receptor signaling pathways
|
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
|
WO2008037732A1
(en)
|
2006-09-29 |
2008-04-03 |
Vib Vzw |
Plant cell lines established from the medicinal plant veratrum californicum
|
|
CA2665343C
(en)
|
2006-10-05 |
2014-12-16 |
The Johns Hopkins University |
Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
|
|
US8198402B2
(en)
|
2006-10-31 |
2012-06-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Smoothened polypeptides and methods of use
|
|
US20080103116A1
(en)
|
2006-11-01 |
2008-05-01 |
Jennings-Spring Barbara L |
Method of treatment and compositions of D-chiro inositol and phosphates thereof
|
|
US20080182859A1
(en)
|
2006-11-02 |
2008-07-31 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
CA2670276A1
(en)
|
2006-11-20 |
2008-05-29 |
Satori Pharmaceuticals, Inc. |
Compounds useful for treating neurodegenerative disorders
|
|
US9231784B2
(en)
|
2006-11-20 |
2016-01-05 |
Thomson Licensing |
Method for eliminating redundant connections
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
WO2008089123A2
(en)
|
2007-01-12 |
2008-07-24 |
Infinity Discovery, Inc. |
Methods for analysis of hedgehog pathway inhibitors
|
|
FI123481B
(fi)
|
2007-02-05 |
2013-05-31 |
Upm Kymmene Corp |
Menetelmä painopaperin valmistamiseksi ja seoskoostumus
|
|
US7964590B2
(en)
|
2007-03-07 |
2011-06-21 |
Infinity Discovery, Inc. |
Cyclopamine lactam analogs and methods of use thereof
|
|
RU2009137014A
(ru)
*
|
2007-03-07 |
2011-04-20 |
Инфинити Дискавери, Инк. (Us) |
Гетероциклические аналоги циклопамина и способы их применения
|
|
MX2009009786A
(es)
|
2007-03-14 |
2009-09-24 |
Exelixis Inc |
Inhibidores de la via de hedgehog.
|
|
DK2137162T3
(en)
|
2007-03-15 |
2018-11-26 |
Novartis Ag |
Organic compounds and their applications
|
|
US9095589B2
(en)
|
2007-04-05 |
2015-08-04 |
Johns Hopkins University |
Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
|
|
CL2008001074A1
(es)
|
2007-04-18 |
2009-06-05 |
Merck & Co Inc |
Uso de compuestos de triazol, antagonistas de smo para tratar cancer.
|
|
US20090054517A1
(en)
|
2007-04-20 |
2009-02-26 |
Lubahn Dennis B |
Phytoestrogens As Regulators Of Hedgehog Signaling And Methods Of Their Use In Cancer Treatment
|
|
EP2175863B1
(en)
|
2007-07-09 |
2018-03-21 |
Eastern Virginia Medical School |
Substituted nucleoside derivatives with antiviral and antimicrobial properties
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
WO2009049258A1
(en)
*
|
2007-10-12 |
2009-04-16 |
The Johns Hopkins University |
Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies
|
|
NZ586121A
(en)
|
2007-12-13 |
2012-03-30 |
Siena Biotech Spa |
Benzimidazole derivatives as hedgehog pathway antagonists and therapeutic applications thereof
|
|
BRPI0821779A2
(pt)
|
2007-12-27 |
2019-09-24 |
Infinity Pharmaceuticals Inc |
tratamento terapêutico de câncer
|
|
EP3190121B1
(en)
|
2007-12-27 |
2019-02-20 |
Infinity Pharmaceuticals, Inc. |
Methods for stereoselective reduction of cyclopamine 4-en-3-one derivative
|
|
US20100297118A1
(en)
|
2007-12-27 |
2010-11-25 |
Macdougall John |
Therapeutic Cancer Treatments
|
|
US20100222287A1
(en)
|
2007-12-27 |
2010-09-02 |
Mcgovern Karen J |
Therapeutic Cancer Treatments
|
|
WO2009099625A2
(en)
|
2008-02-08 |
2009-08-13 |
The Board Of Regents Of The University Of Texas System |
Cyclopamine tartrate salt and uses thereof
|
|
US20090246841A1
(en)
|
2008-03-26 |
2009-10-01 |
Jamieson Andrew C |
Methods and compositions for production of acetaldehyde
|
|
US20110217294A1
(en)
|
2008-04-11 |
2011-09-08 |
Daniel Fults |
Combination of hgf inhibitor and hedgehog inhibitor to treat cancer
|
|
CL2009001479A1
(es)
|
2008-07-02 |
2010-01-04 |
Infinity Pharmaceuticals Inc |
Metodo para aislar un alcaloide del veratrum desglicosilado que comprende proporcionar un material de planta veratrum, poner en contacto con una solucion acuosa y extraer el material de la planta veratrum con un solvente para proporcionar un extracto que comprende dicho alcaloide.
|
|
CA2636807A1
(en)
|
2008-07-04 |
2010-01-04 |
Steven Splinter |
Methods for obtaining cyclopamine
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
WO2010033481A1
(en)
|
2008-09-17 |
2010-03-25 |
Novartis Ag |
Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
|
|
WO2010034032A2
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutic, Inc. |
Methods for preparing purified polypeptide compositions
|
|
US20100081637A1
(en)
|
2008-10-01 |
2010-04-01 |
Innovia Skincare Corp. |
Eczema treatment with vitamin D and analogs thereof method, composition and cream
|
|
JP2012515792A
(ja)
|
2009-01-23 |
2012-07-12 |
キャンサー・リサーチ・テクノロジー・リミテッド |
ヘッジホッグ経路阻害剤
|
|
AR077490A1
(es)
|
2009-07-21 |
2011-08-31 |
Novartis Ag |
Composiciones farmaceuticas topicas para el tratamiento de una condicion hiperproliferativa de la piel
|
|
AU2010279325B2
(en)
|
2009-08-05 |
2016-10-20 |
Infinity Pharmaceuticals, Inc. |
Enzymatic transamination of cyclopamine analogs
|
|
EP2501237A1
(en)
*
|
2009-11-06 |
2012-09-26 |
Infinity Pharmaceuticals, Inc. |
Oral formulations of a hedgehog pathway inhibitor
|
|
EP2502078A1
(en)
|
2009-11-20 |
2012-09-26 |
Infinity Pharmaceuticals, Inc. |
Methods and compositions for treating hedgehog-associated cancers
|
|
US20110183948A1
(en)
|
2010-01-15 |
2011-07-28 |
Infinity Pharmaceuticals, Inc. |
Treatment of fibrotic conditions using hedgehog inhibitors
|
|
GB201010954D0
(en)
|
2010-06-29 |
2010-08-11 |
Edko Pazarlama Tanitim Ticaret |
Compositions
|
|
WO2012006584A2
(en)
|
2010-07-08 |
2012-01-12 |
Infinity Pharmaceuticals, Inc. |
Therapeutic regimens for hedgehog-associated cancers
|
|
US20120010230A1
(en)
|
2010-07-08 |
2012-01-12 |
Macdougall John R |
Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
|
|
WO2012037217A1
(en)
|
2010-09-14 |
2012-03-22 |
Infinity Pharmaceuticals, Inc. |
Transfer hydrogenation of cyclopamine analogs
|
|
CN102085176A
(zh)
|
2010-12-31 |
2011-06-08 |
江苏中丹制药有限公司 |
一种纳米级伊曲康唑外用制剂、其制备方法及其用途
|
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
|
EP2753179A4
(en)
|
2011-09-09 |
2015-03-04 |
Univ Leland Stanford Junior |
TOPICAL ITRACONAZOLE FORMULATIONS AND THEIR USE
|
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
|
NZ708371A
(en)
|
2012-12-14 |
2020-05-29 |
Trevi Therapeutics Inc |
Methods for treating pruritus
|
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
|
AU2015237050B2
(en)
|
2014-03-24 |
2019-05-09 |
Guangdong Zhongsheng Pharmaceutical Co., Ltd |
Quinoline derivatives as SMO inhibitors
|
|
MX387917B
(es)
|
2015-06-04 |
2025-03-19 |
Pellepharm Inc |
Formulaciones topicas para suministrar compuestos inhibidores de hedgehog y uso de los mismos.
|
|
US20170231968A1
(en)
|
2016-02-11 |
2017-08-17 |
PellePharm, Inc. |
Method for relief of and treatment of pruritus
|